ArticleNaunyn-Schmiedeberg's archives of pharmacology2023

Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway.

Yingwen Bai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.